HIF1A and Alzheimer disease: Although the role of HIF-1 signalling in the development of AD-related neurodegeneration is rather controversial (Chai et al., 2014; Guo et al., 2017; Kim et al., 2017; Lu et al., 2018), increasing evidence has identified HIF-1α as a potential therapeutic target for AD (Wang et al., 2021b).